Clinical Trial Update: Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus Osteomyelitis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating vancomycin or trimethoprim/sulfamethoxazole for MRSA osteomyelitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection
• Osteomyelitis

Drugs mentioned

• Trimethoprim-sulfamethoxazole (trimethoprim-sulfamethoxazole)
• Vancomycin (vancomycin)

Snippet

Sponsor: University of Washington | Conditions: Osteomyelitis, Methicillin-resistant Staphylococcus Aureus | Phase 3 | Status: COMPLETED